-+ 0.00%
-+ 0.00%
-+ 0.00%

Ping An Biomedical Plans to Buy Three Tumor-Related Patents for USD 2 Million–2.5 Million

PUBT·10/26/2026 12:32:06
Listen to the news
Ping An Biomedical Plans to Buy Three Tumor-Related Patents for USD 2 Million–2.5 Million
  • Ping An Biomedical signed a letter of intent to acquire three tumor-related medical technology patents from Future Biotechnology Group for USD 2 million–USD 2.5 million.
  • The planned acquisition would establish a core oncology and biotechnology intellectual property portfolio to support longer-term healthcare development.
  • No material near-term revenue is expected from the acquisition alone.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-112291), on October 26, 2026, and is solely responsible for the information contained therein.